Makras, Polyzois
Anastasilakis, Athanasios D.
Antypas, George
Chronopoulos, Efstathios
Kaskani, Evangelia G.
Matsouka, Aikaterini
Patrikos, Dimos K.
Stathopoulos, Konstantinos D.
Tournis, Symeon
Trovas, George
Kosmidis, Christos
Article History
Received: 15 January 2019
Accepted: 25 February 2019
First Online: 15 March 2019
Compliance with ethical standards
:
: -PM has received lecture fees and research grants from Amgen and lecture fees from Glaxo, Eli-Lilly, Pfizer, Leo, Genesis, ELPEN, VIANEX, Rafarm, Galenica, and UniPharma.-ADA has received lecture fees from Amgen, Eli-Lilly, ELPEN, ITF Hellas, Rafarm, and VIANEX.-GA has nothing to disclose.-EC has received lecture and/or advisory board fees from Eli-Lilly and Vianex.-EGK has received lecture and/or advisory board fees or research grants from Amgen, ELPEN, MSD, Novartis, UCB, Vianex, and Inovis.-AM has received lecture fees from Merck Sharp & Dohme, UCB, Eli-Lilly, Novartis, Roche, Amgen, Angelini, Janssen-Cilag, and Genesis.-DKP has received lecture and/or advisory board fees from Abbvie, AENORASIS, Amgen, Eli-Lilly, Galenica, Genesis, Menarini Hellas, MSD, Novartis, Pfizer, Rafarm, Sandoz, UCB, and Vianex.-KDS has received lecture fees and advisory board fees from Amgen Hellas and honoraria and lecture fees from Pharmaserve Lilly, Specifar a Teva, and VIANEX.-ST has received lecture and/or advisory board fees from Amgen, Lilly, Vianex, ITF Hellas, Merck Biopharma Greece, Galenica, and Shire Hellas.-GT has received lecture and advisory board fees from Farmaserv-Lilly, Amgen Hellas, Servier, Vianex, ITF Hellas, Merck Hellas, Astra Zeneca, GSK, and Valeant Bausch Health.-CK has received lecture and/or advisory board fees from Amgen, Eli-Lilly, and VIANEX, and lecture fees from Galenica.